Nokea
A 22-year-old nursing student has been taking caffeine tablets for the past few weeks to 'make it through' the end of the semester and exam week. She is in the university clinic today because she is 'exhausted.' What human needs statement may be appropriate for her?
- A. Altered oxygenation need
- B. Altered physical activity
- C. Altered need for sleep
- D. Altered food intake
Correct Answer: C
Rationale: Caffeine, a CNS stimulant, can cause restlessness, anxiety, and insomnia, leading to an altered need for sleep. This is the most relevant human needs statement given her exhaustion from overuse. The other options are not directly related to caffeine's effects.
You may also like to solve these questions
A patient is receiving instructions regarding the use of caffeine. The nurse shares that caffeine should be used with caution if which of these conditions is present?
- A. A history of peptic ulcers
- B. Migraine headaches
- C. Asthma
- D. A history of kidney stones
Correct Answer: A
Rationale: Caffeine can exacerbate peptic ulcers by increasing gastric acid secretion, which may worsen the condition. It is not contraindicated in migraine headaches, asthma, or kidney stones, though it may have varying effects on these conditions.
When evaluating a patient who is taking orlistat, which is an intended therapeutic effect?
- A. Increased wakefulness
- B. Increased appetite
- C. Decreased weight
- D. Decreased hyperactivity
Correct Answer: C
Rationale: Orlistat is a nonstimulant drug used for weight loss by inhibiting fat absorption, making decreased weight the intended therapeutic effect. It does not affect wakefulness, appetite, or hyperactivity.
The nurse is teaching a patient how to self-administer triptan injections for migraine headaches. Which statement by the patient indicates that he needs further teaching?
- A. I will take this medication regularly to prevent a migraine headache from occurring.'
- B. I will take this medication when I feel a migraine headache starting.'
- C. This medication will not reduce the number of migraines I will have.'
- D. I will keep a journal to record the headaches I have and how the injections are working.'
Correct Answer: A
Rationale: Triptans are used to treat acute migraine attacks, not to prevent them. The patient's statement about taking the medication regularly for prevention indicates a misunderstanding, requiring further teaching. The other statements align with proper triptan use.
The nurse is reviewing the use of central nervous system stimulants. Which of these are indications for this class of drugs? (Select all that apply.)
- A. Narcolepsy
- B. Depression
- C. Panic attacks
- D. Neonatal apnea
- E. Attention deficit hyperactivity disorder (ADHD)
- F. Appetite suppression
- G. Migraine headaches
Correct Answer: A,D,E,F,G
Rationale: CNS stimulants are indicated for narcolepsy, neonatal apnea, ADHD, appetite suppression in obesity treatment, and migraine headaches (via triptans). They are not used for depression or panic attacks, as they may worsen these conditions.
A 6-year-old boy has been started on an extended-release form of methylphenidate hydrochloride for the treatment of attention deficit hyperactivity disorder (ADHD). During a follow-up visit, his mother tells the nurse that she has been giving the medication at bedtime so that it will be 'in his system' when he goes to school the next morning. What is the nurse's appropriate evaluation of the mother's actions?
- A. She is giving him the medication dosage appropriately.
- B. The medication should not be taken until he is at school.
- C. The medication should be taken with meals for optimal absorption.
- D. The medication should be given 4 to 6 hours before bedtime to diminish insomnia.
Correct Answer: D
Rationale: Methylphenidate, a CNS stimulant, can cause insomnia if taken close to bedtime. Administering it 4 to 6 hours before bedtime helps minimize sleep disturbances while maintaining therapeutic levels during the day. Bedtime dosing, school-time dosing, or meal-dependent administration are not appropriate for extended-release formulations.